GLP-1 Receptor Agonists Combined with Healthy Habits Significantly Reduce Cardiovascular Risk

A recent study published in The Lancet Diabetes & Endocrinology demonstrates that combining glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with adopting healthy lifestyle habits can substantially reduce the risk of major adverse cardiovascular events (MACE) in individuals with type 2 diabetes .

The Synergistic Effect of Medication and Lifestyle

Researchers found that lifestyle interventions aren’t superseded by modern medications; instead, they amplify the benefits of treatments like GLP-1 RAs. “Our findings underscore that, even in the era of highly effective GLP-1 pharmacotherapy, lifestyle habits remain central to diabetes management and cardiovascular risk reduction and can substantially amplify the benefits of modern medications,” explained Dr. Frank Hu of Harvard T.H. Chan School of Public Health .

Study Details and Methodology

The study analyzed data from over 98,000 adults with type 2 diabetes and no prior history of cardiovascular disease. Researchers assessed adherence to eight healthy habits:

• Maintaining a healthy diet
• Regular physical activity
• Adequate sleep
• Healthy body weight
• Avoiding smoking
• Moderate alcohol consumption
• Stress management
• Social connection

The MACEs considered included myocardial infarction, stroke, and cardiovascular death.

Key Findings on Risk Reduction

The research revealed a significant reduction in MACE risk for those combining GLP-1 RA use with a healthy lifestyle. Specifically:

• Individuals using a GLP-1 RA and adhering to six to eight healthy habits experienced a 43% lower risk of MACE compared to those not using a GLP-1 RA and adhering to three or fewer habits.
• Those consistently practicing all eight healthy habits demonstrated a 60% reduced risk of MACE compared to those practicing one or fewer.
• GLP-1 RA use alone was associated with a 16% lower MACE risk.

GLP-1 Receptor Agonists and Cardiovascular Health

GLP-1 receptor agonists are established treatments for type 2 diabetes, known for their ability to improve glycemic control. Still, research increasingly highlights their broader benefits, including cardioprotective effects and a reduction in the risk of major adverse cardiovascular events and .

The Importance of a Holistic Approach

Experts emphasize the importance of a comprehensive approach to diabetes and cardiovascular health. “We know that GLP-1 receptor agonists can improve cardiovascular health in patients with diabetes. We too know that good lifestyle habits…are all beneficial in controlling the risk factors that lead to heart disease,” stated Dr. Cheng-Han Chen, an interventional cardiologist .

Dr. Hu added that population-level investments in promoting healthy habits remain crucial, even with the availability of novel therapies. “As novel therapies expand, scalable lifestyle interventions remain essential for reducing the overall burden of cardiovascular disease and other chronic diseases.”

Study Limitations

Researchers acknowledged limitations, including the observational nature of the data, which introduces the possibility of confounding factors. The study population also primarily consisted of white male veterans, potentially limiting the generalizability of the findings. However, the results remained consistent across different racial and ethnic groups and between males and females.

Practical Recommendations

Maintaining diabetes control is an ongoing process. Experts recommend focusing on:

• Making informed food choices
• Engaging in regular physical activity
• Avoiding alcohol and tobacco
• Prioritizing quality sleep